Изображения являются только для ссылки
EG27324
+БОМ-
ПроизводительEG Микро
-
Мфр. Часть #EG27324
-
Лист данных EG27324 DataSheet
-
В наличии15972
365 Дни гарантии качества
7*24 часы обслуживания каранти
90-гарантия послепродажного дня
Гарантия подлинного продукта
Спецификации
| Атрибут | Ценность |
| Manufacturer | EG Micro |
| Package / Case | SOP-8 |
| Voltage - Supply | 2.8V~20V |
| Operating Temperature | -45℃~+125℃ |
| Current - Output | 2.5A |
Обзор
Equivalent
- IR2104 (International Rectifier)
- TC4427 (Microchip)
- MIC4427 (Microchip)
- FAN7382 (ON Semiconductor)
- UCC27324 (Texas Instruments)
These alternatives offer similar high-speed, high-current gate driving capabilities. Verify pin compatibility and specifications for your application.
Features
- Core: 32-bit ARM Cortex-M4 with FPU (up to 120 MHz)
- Memory: 512 KB Flash, 128 KB SRAM
- Connectivity: USB 2.0, UART, SPI, I2C, CAN
- Analog: 12-bit ADC (16 channels), 12-bit DAC
- Timers: Multiple 16/32-bit timers, PWM support
- Power Efficiency: Low-power modes (Sleep, Stop, Standby)
- Operating Voltage: 1.8V–3.6V
- Packages: LQFP64, QFN48
- Security: Hardware encryption, CRC, RNG
- Temperature Range: -40°C to +85°C
Ideal for embedded applications requiring efficiency and connectivity.
Pinout
- Pin Count: 8 pins (SOIC-8 package).
- Functions:
1. VCC: Power supply input (10V-20V).
2. GND: Ground reference.
3. IN1/IN2: Logic input signals for each channel.
4. OUT1/OUT2: High-current gate drive outputs.
5. SD: Shutdown control (active low).
6. NC: No connection (unused pin).
It provides high-speed switching, under-voltage lockout (UVLO), and cross-conduction prevention for MOSFETs/IGBTs.
Application
1. Cancer Therapy: Investigated for inhibiting tumor growth by targeting specific signaling pathways.
2. Anti-inflammatory Treatments: Potential use in reducing inflammation in autoimmune diseases.
3. Neuroprotection: Studied for protecting neurons in neurodegenerative conditions like Alzheimer’s.
4. Metabolic Disorders: Explored for modulating metabolic pathways in diabetes and obesity.
Its precise applications remain under preclinical or early-stage research, with no widespread clinical use yet.